← back to search

Taisuke Mori

Kyoto Prefectural University of Medicine · JP
Area of research
Surgery · Otorhinolaryngology
Research interest
Research interests include Head and Neck Cancer Studies, Sarcoma Diagnosis and Treatment, Salivary Gland Tumors Diagnosis and Treatment, and Cancer-related Molecular Pathways.
h-index
36
citations
5,612
works
236
NIH funding
primary concept
Medicine
email

Recent publications

Late-Onset Bilateral Malignant Ciliary Body Medulloepithelioma in an Adult.
2026cited by 0position: contributordoi
Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour.
2025cited by 3position: contributordoi
Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy.
2025cited by 1position: contributordoi
Abnormal nuclear and nucleolar immunoreactivity of p16INK4a represents a frameshift alteration in CDKN2A: the E6H4 clone recognizes the "p14ARF::p16INK4a" chimeric protein.
2025cited by 0position: contributordoi
Unusual Case of a Sporadic Juvenile Polyp Coexisting With Traditional Serrated Adenoma in the Colon.
2025cited by 0position: contributordoi
Merkel Cell Carcinosarcoma: Wnt Pathway Activation Associated With Sarcomatoid Transformation.
2025cited by 0position: contributordoi
Relationship Between Short-Term Outcomes and PD-L1 Expression Based on Combined Positive Score and Tumor Proportion Score in Recurrent or Metastatic Head and Neck Cancers Treated With Anti-PD-1 Antibody Monotherapy.
2025cited by 0position: contributordoi
Secondary Angiosarcoma of the Thigh Arising From Lymphedema After Post-Operative Radiotherapy for Extramammary Paget's Disease: A Case Report.
2025cited by 0position: contributordoi
High-grade intraductal carcinoma of the parotid gland harboring CTNNA1::ALK rearrangement: Changes in genetic status using genetic testing during treatment with an ALK inhibitor.
2024cited by 3position: contributordoi
Pediatric Mesenchymal Tumor With MN1::TAF3 Fusion.
2024cited by 2position: contributordoi
Low-grade carcinoma with acinic cell carcinoma-like features of the parotid gland with CRTC3::IQGAP1 fusion.
2024cited by 1position: contributordoi
Retinal gliosis with osseous metaplasia in an infant.
2024cited by 0position: contributordoi
Clinical outcomes of head and neck mucosal melanoma treated with surgery: a single-center study in Japan.
2023cited by 2position: contributordoi
Identification of novel SSX1 fusions in synovial sarcoma.
2022cited by 30position: contributordoi
Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall.
2022cited by 17position: contributordoi
Involvement of the p53-p16/RB pathway control mechanism in early-stage carcinogenesis in head and neck squamous cell carcinoma.
2022cited by 13position: contributordoi
Recurrent FOS rearrangement in proliferative fasciitis/proliferative myositis.
2021cited by 12position: contributordoi
RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma.
2021cited by 4position: contributordoi
Prognostic Value of Epithelial Cell Adhesion Molecules in T1-2N0M0 Glottic Cancer.
2021cited by 4position: contributordoi
Method for diagnosing neoplastic lesions by quantitative fluorescence value.
2019cited by 12position: contributordoi
β-Arrestin 1 (ARRB1) serves as a molecular marker of the peripheral circadian rhythm.
2019cited by 12position: contributordoi
Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy.
2019cited by 10position: contributordoi
Clinical impact of a cytological screening system using cyclin D1 immunostaining and genomic analysis for the diagnosis of thyroid nodules.
2019cited by 7position: contributordoi
Common carotid artery ligation at the proximal side before rupture in patients with ligation or occlusion of the external carotid artery at risk of carotid blowout syndrome.
2019cited by 2position: contributordoi
ASO Author Reflections: Precise p53 Analysis in Formalin-Fixed Paraffin-Embedded Specimens Can Predict Head and Neck Squamous Cell Carcinoma Outcomes.
2019cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 11 papers (2019–2026)Yasushi Yatabe · The Cancer Institute Hospital6 papers (2021–2026) · 6 papers (2021–2026)Akihiko Yoshida · National Cancer Centre Japan4 papers (2022–2025)Yasuhito Arai · National Cancer Centre Japan2 papers (2022–2022) · 2 papers (2022–2022)Kaishi Satomi · National Cancer Center Hospital East2 papers (2022–2022)Eiji Nakano · Kobe University Hospital2 papers (2023–2025) · 2 papers (2019–2023)Dai Ogata · Peking University Cancer Hospital2 papers (2023–2025)Koichi Ichimura · Kyorin University2 papers (2022–2022)Kenya Kobayashi · Elsevier, Inc.2 papers (2019–2023)Naoya Yamazaki · The University of Osaka2 papers (2023–2025)Hitoshi Ichikawa · National Cancer Research Institute2 papers (2022–2022)Kenjiro Namikawa · The University of Osaka2 papers (2023–2025)Tetsuo Ushiku · Japanese Urological Association1 papers (2021–2021)Eiichi Morii · Kuma Hospital1 papers (2024–2024)Toshikazu Ushijima · Hoshi University1 papers (2022–2022)Toshihide Ueno · Shikoku Cancer Center1 papers (2026–2026)Kana Takahashi · Springer Nature1 papers (2019–2019)